Document is current
Any future updates will be listed below
-
Authors
Wijayaratna, Dhanushan
Sacchetta, Filippo
Pedraza-González, Laura
Fanelli, Francesca
Sugihara, Tomohiro
Koyanagi, Mitsumasa
Piyawardana, Senuri
Ghotra, Kiran
Thotamune, Waruna
Terakita, Akihisa
Olivucci, Massimo
Karunarathne, Ajith
-
Funding
Funding for this research was provided by:
NIH-NIGMS (1R01GM140191-01)
NIH-NIGMS (1R01GM140191-01)
NIH-NIGMS (1R01GM140191-01)
NIH-NIGMS (1R01GM140191-01)
NIH-NIGMS (1R01GM140191-01)
National Center for Gene Therapy and Drugs based on RNA Technology (CN00000041 CN3 RNA)
National Center for Gene Therapy and Drugs based on RNA Technology (CN00000041 CN3 RNA)
National Center for Gene Therapy and Drugs based on RNA Technology (CN00000041 CN3 RNA)
National Center for Gene Therapy and Drugs based on RNA Technology (CN00000041 CN3 RNA)
NSF CHE-SDM A (2102619)
NSF CHE-SDM A (2102619)
NSF CHE-SDM A (2102619)
NSF CHE-SDM A (2102619)
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 17 July 2024
First Online: 8 August 2024
Declarations
:
: The authors declare no competing interests.
